Market closedNon-fractionalADR
Teva Pharmaceutical/TEVA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Teva Pharmaceutical
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Ticker
TEVA
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
Headquarters
Tel aviv-yafo, Israel
Employees
35,001
Website
www.tevapharm.com
TEVA Metrics
BasicAdvanced
$19B
Market cap
-
P/E ratio
-$0.44
EPS
0.91
Beta
-
Dividend rate
Price and volume
Market cap
$19B
Beta
0.91
52-week high
$17.13
52-week low
$7.12
Average daily volume
207
Financial strength
Current ratio
0.892
Quick ratio
0.605
Long term debt to equity
227.865
Total debt to equity
269.909
Interest coverage (TTM)
4.36%
Management effectiveness
Return on assets (TTM)
-1.84%
Return on equity (TTM)
-6.51%
Return on investment (TTM)
-2.60%
Valuation
Price to revenue (TTM)
1.177
Price to book
2.635
Price to free cash flow (TTM)
21.471
Growth
Revenue change (TTM)
7.22%
Earnings per share change (TTM)
71.34%
3-year revenue growth (CAGR)
-1.65%
What the Analysts think about TEVA
Analyst Ratings
Majority rating from 13 analysts.
TEVA Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.8B
-14.31%
Net income
-$139M
-132.40%
Profit margin
-3.63%
-137.73%
TEVA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.56
$0.60
$1.00
$0.48
-
Expected
$0.53
$0.61
$0.77
$0.51
$0.58
Surprise
6.64%
-1.38%
30.29%
-6.67%
-
TEVA News
AllArticlesVideos
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs
Seeking Alpha·12 hours ago
Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
MarketBeat·2 weeks ago
Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractionalADR
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Teva Pharmaceutical stock?
Teva Pharmaceutical (TEVA) has a market cap of $19B as of July 27, 2024.
What is the P/E ratio for Teva Pharmaceutical stock?
The price to earnings (P/E) ratio for Teva Pharmaceutical (TEVA) stock is 0 as of July 27, 2024.
Does Teva Pharmaceutical stock pay dividends?
No, Teva Pharmaceutical (TEVA) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Teva Pharmaceutical dividend payment date?
Teva Pharmaceutical (TEVA) stock does not pay dividends to its shareholders.
What is the beta indicator for Teva Pharmaceutical?
Teva Pharmaceutical (TEVA) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Teva Pharmaceutical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.